Case Number:

IPR2021-01577

Case Type:

IPR

Status:

Trial Instituted

Petitioner:

STRECK, INC.

Patent Owner:

Ravgen, Inc.

Tech Center:

1600

1. Filed: September 28, 2021 00:00

   Coverage

   1. April 19, 2023

      PTAB Upholds DNA Testing Patents Key To $272M Ravgen Win

      The Patent Trial and Appeal Board has rejected biotechnology company Streck's contention that nearly 30 claims in a Ravgen genetic testing patent are obvious or anticipated, siding with the patent owner in yet another challenge to the testing system it had used to score $272 million in infringement damages in underlying litigation.

   1 other articles on this case. View all »

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login